Sign up
Log in
12 Health Care Stocks Moving In Thursday's Intraday Session
Share
Listen to the news

Gainers

  • Healthcare Triangle (NASDAQ:HCTI) shares moved upwards by 270.6% to $0.03 during Thursday's regular session. The company's market cap stands at $13.9 million.
  • Liminatus Pharma (NASDAQ:LIMN) shares moved upwards by 51.3% to $16.81. The market value of their outstanding shares is at $437.3 million.
  • Klotho Neurosciences (NASDAQ:KLTO) shares moved upwards by 42.76% to $2.07. The company's market cap stands at $67.2 million.
  • Reshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 34.49% to $3.08. The company's market cap stands at $2.2 million.
  • Sagimet Biosciences (NASDAQ:SGMT) shares increased by 30.69% to $8.09. The company's market cap stands at $260.4 million.
  • Polyrizon (NASDAQ:PLRZ) shares moved upwards by 30.06% to $1.04. The company's market cap stands at $5.5 million.

Losers

  • Intensity Therapeutics (NASDAQ:INTS) stock fell 45.1% to $0.32 during Thursday's regular session. The market value of their outstanding shares is at $5.8 million.
  • Helius Medical Tech (NASDAQ:HSDT) stock declined by 44.14% to $0.62.
  • Shuttle Pharmaceuticals (NASDAQ:SHPH) shares declined by 33.35% to $0.15. The company's market cap stands at $1.6 million.
  • Jupiter Neurosciences (NASDAQ:JUNS) stock declined by 33.17% to $1.33. The company's market cap stands at $44.0 million.
  • Catheter Precision (AMEX:VTAK) shares declined by 27.83% to $0.43. The company's market cap stands at $4.7 million.
  • Simulations Plus (NASDAQ:SLP) shares decreased by 22.28% to $20.55. The market value of their outstanding shares is at $413.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.